Please login to the form below

Not currently logged in

People, October, 2006

Following the agreement for Nycomed to acquire Altana Pharma, it is proposed that on approval of the 4.215bn transaction Dr Hakan Bjorklund will serve as chief executive officer of the combined group
Following the agreement for Nycomed to acquire Altana Pharma, it is proposed that on approval of the 4.215bn transaction Dr Hakan Bjorklund will serve as chief executive officer of the combined group, which will operate under the Nycomed corporate brand name. Toni Weitzberg, Nycomed's present chairman of the board, will continue in this role within the combined group.

Archimedes Pharma has recruited Dr Mark Watling as medical director. He has more than 10 years' experience of the pharmaceutical industry at a senior level, having served most recently as head of medical partnerships at Novo Nordisk. Dr Miranda Penhaligon has joined the company, as clinical operations director, from Quintiles, where she was group project director, Oncology.

Sanofi-aventis has named Dr Heinz-Werner Meier as senior vice-president, human resources, succeeding Jean-Claude Armbruster who has become senior vice-president, adviser to the chairman for employee relations. Dr Meier has been on S-A's board since May 2003.

Cambridge-based operation Cenes Pharmaceuticals has appointed to its scientific advisory board Professor Robert Sneyd, associate dean and professor of anaesthesia at Peninsula Medical School, and Professor Peter Glass, who is professor and chairman in the Stony Brook University Hospital`s anaesthesiology department.

The Biosciences Federation has appointed Professor Richard Bateman as head of policy and Dr Caroline Wallace as policy co-ordinator. Professor Bateman will work with CEO Dr Richard Dyer to promote the views of the UK's bioscientists to the government in such matters as education, research and funding.

Swiss pharma firm Santhera Pharmaceuticals has appointed M J Roach as vice-president, marketing and sales. She has more than 20 years' experience of marketing, sales and senior management in the pharmaceutical industry. The firm has also announced two recent appointments to its non-executive board of directors: Hans Peter Hasler is currently senior vice-president and head of international business at Biogen Idec, and Martin Gertsch was recently chief financial officer of the Straumann Group.

Bionest Partners has announced the appointment of Lionel Delaporte as director and head of the company's pharmaceutical practice. Lionel has held several management positions at a variety of strategic healthcare consulting and research companies, including ISO Health Care Consulting, Monitor and Smart Pharma Consulting.

Phytopharm has announced that Gordon Stevens (non-executive chairman) and Trevor Flanagan (non-executive director) have retired from the board, while Paul Whitney (the current deputy chairman) has stepped into the role of non-executive chairman.

Recruitment consultancy Chase has appointed Catherine Fitch as sales development consultant at its head office in Edinburgh. The company provides contract nurse teams, medical sales personnel and other vacancy management services.

Andrew Worsfold has been recruited by Resolute to be associate director. He brings with him broad experience of medical communications and PR, after having served in senior roles at several major firms spanning the pharmaceutical, diagnostics and biotechnology industries. The company has also hired Dr Alister Sansum as an account director, who joins from Discovery Health. He has a degree and a PhD in pharmacology and has more than eight years' experience in agency medical communications.


Healthcare public affairs agency Advocate, headed by former Labour Party press officer Jamie Holyer, has appointed Rachel Cunningham as a consultant. A former health researcher for the Liberal Democrat Party, she will assist Holyer in his search for new business. She has experience of advising Pfizer, Wyeth and Abbott on their responses to the government's healthcare policy environment.

Shire Health London has promoted Sian Boisseau from the position of associate director to the role of client services director. She has nine years of healthcare communications experience and joined the company in 2001, as an account manager.

Healthcare comms agency Onyx Health has recruited Jane Wrenn as a senior associate. Reporting directly to partners Karen Winterhalter and Penelope Wright, she will manage part of the firm's Teva/Lundbeck and Cephalon business, as well as take on responsibility for new business and marketing. Previously, all three colleagues served together at Weber Shandwick.

Gail Rowe, client services director at LeapFrog Medical Communications, has joined the Pharmaceutical Marketing Society's committee. She has more than 10 years' experience of running medical education projects in the UK and currently oversees all of LeapFrog's pharma business. For more help and information on pharmaceutical marketing, visit and has hired Rupert Potter to the newly created post of business development manager. He has eight years' experience of the pharma industry and joins the company from AstraZeneca where he served in primary and secondary sales and marketing.

Adam Toms is the new head of communications and marketing at the Postgraduate Medical Education and Training Board. He takes over the role from Paul Wellings, who was providing interim cover.

Lifescience comms firm Northbank Communications has appointed Tony Stephenson as account manager, media relations. He served previously as press officer at Imperial College London.

Executive search company Ruston Poole International has appointed Dr Alan Wood as director of international search. He worked formerly as part of the global senior management team at Covance, and has also served at Quintiles and Novartis.

Liz Saunders has launched Training Central, a learning management system designed for training pharmaceutical salesforces. She serves as commercial director for the company and has worked previously in market research, contract sales and e-business.

Succinct Healthcare Communications, a medical education agency, has recruited Antoine Ramjaun as account executive. He joins the firm from Cancer Research UK where he spent several years building up a knowledge of oncology and the mechanisms of carcinogenesis. In his new role, he will work alongside Succinct's directors to deliver key opinion leader programmes and consultancy services.

Marketing and comms agency Courts has appointed Martyn Wadsworth as the firm's director of healthcare marketing. Following a career in research at the NHS, he spent the subsequent 26 years in sales and marketing roles at major healthcare companies, including a stint in marketing communications for Bayer Diabetes Care in Europe. He has served on the agency side of healthcare marketing since 2003.

ScopeMedical has announced four new appointments: with three years of medical comms experience, Emily Surridge joins as a senior medical writer. Ryan Hamsher joins the studio team as an artworker. He has more than five years' experience of design and artworking. Alison Davies is a new project manager at the company. She served formerly in a similar role for Quantum Medical Communications and has 10 years' prior experience of the pharmaceutical sector. Lauren Garcia joins the firm as a project assistant and will be involved primarily in the administration of the Patient Voices Programme.


COVID-19 Updates and Daily News

Featured jobs


Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world